|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 257.58 USD | -1.20% |
|
+2.02% | +6.94% |
| 01-12 | ResMed Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 10:30 AM | |
| 01-09 | Resmed Insider Sold Shares Worth $497,660, According to a Recent SEC Filing | MT |
| Capitalization | 37.52B 32.35B 30.11B 28.03B 52.19B 3,404B 56.16B 346B 137B 1,624B 141B 138B 5,929B | P/E ratio 2026 * |
24.5x | P/E ratio 2027 * | 22x |
|---|---|---|---|---|---|
| Enterprise value | 36.29B 31.29B 29.13B 27.11B 50.48B 3,293B 54.32B 335B 132B 1,571B 136B 133B 5,735B | EV / Sales 2026 * |
6.48x | EV / Sales 2027 * | 5.88x |
| Free-Float |
76.64% | Yield 2026 * |
0.94% | Yield 2027 * | 1.03% |
Last Transcript: ResMed, Inc.
| 1 day | -1.20% | ||
| 1 week | +2.02% | ||
| Current month | +6.94% | ||
| 1 month | +4.73% | ||
| 3 months | -3.92% | ||
| 6 months | +0.45% | ||
| Current year | +6.94% |
| 1 week | 250.32 |  | 262.87 |
| 1 month | 240 | | 262.87 |
| Current year | 240 | | 262.87 |
| 1 year | 199.92 | | 293.81 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 52.37 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 01/03/2013 |
Brett Sandercock
DFI | Director of Finance/CFO | 59 | 01/01/2006 |
Jim Ellis
CMP | Compliance Officer | - | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 53 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 01/06/1989 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.50% | 1.09% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.20% | +2.02% | +7.42% | +14.29% | 37.52B | |
| -0.95% | -0.02% | +10.55% | +5.25% | 232B | |
| -1.17% | -8.74% | -9.73% | +104.41% | 190B | |
| -1.63% | -1.00% | -0.99% | -14.16% | 167B | |
| -2.18% | -9.80% | -10.73% | +91.29% | 131B | |
| -1.07% | -0.45% | -11.20% | -7.07% | 59.92B | |
| -0.17% | -0.92% | +20.88% | +6.96% | 48.95B | |
| -3.58% | -5.98% | -5.24% | -10.14% | 39.59B | |
| -0.92% | -6.34% | -3.53% | +29.09% | 37.24B | |
| -1.42% | -1.22% | -13.97% | -40.71% | 34.92B | |
| Average | -1.43% | -3.45% | -1.65% | +17.92% | 97.76B | |
| Weighted average by Cap. | -1.37% | -3.78% | -1.18% | +30.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.6B 4.83B 4.5B 4.19B 7.79B 508B 8.38B 51.71B 20.39B 242B 21.01B 20.57B 885B | 6.02B 5.19B 4.83B 4.5B 8.37B 546B 9.01B 55.58B 21.91B 261B 22.58B 22.11B 951B |
| Net income | 1.54B 1.32B 1.23B 1.15B 2.14B 139B 2.3B 14.17B 5.59B 66.45B 5.76B 5.64B 243B | 1.71B 1.48B 1.37B 1.28B 2.38B 155B 2.56B 15.8B 6.23B 74.06B 6.42B 6.29B 270B |
| Net Debt | -1.23B -1.06B -986M -918M -1.71B -111B -1.84B -11.34B -4.47B -53.17B -4.61B -4.51B -194B | -2.09B -1.8B -1.68B -1.56B -2.91B -190B -3.13B -19.31B -7.61B -90.53B -7.84B -7.68B -331B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 257.58 $ | -1.20% | 955,388 |
| 15/01/26 | 260.70 $ | +0.46% | 939,968 |
| 14/01/26 | 259.51 $ | +1.90% | 970,429 |
| 13/01/26 | 254.67 $ | -1.23% | 1,071,442 |
| 12/01/26 | 257.84 $ | +2.13% | 1,111,489 |
Delayed Quote Nyse, January 17, 2026 at 12:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition